Please assess the completion status of the following clinical trial:

Trial Title: Assessing Symptomatic Clinical Episodes in Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Currently meets DSM-5 criteria for MDD~* Body mass index (BMI) between 18 and 40 kg/m\^2, inclusive~* Agree to use adequate method of contraception for the duration of the study~* Additional criteria may apply~Exclusion Criteria:~* Suicide risk~* History of treatment resistance in current depressive episode~* History of electroconvulsive therapy, vagus nerve stimulation, transcranial magnetic stimulation or any experimental central nervous system treatment during the current episode or in the past 6 months~* Pregnant, breastfeeding, or planning to become pregnant or breastfeed during the study~* Additional criteria may apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- AXS-05 (Type: EXPERIMENTAL): None
- Bupropion (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).